Get the Stockscreener App
187.15
1.55%
-2.95
After Hours:
187.15
Overview
News
Price History
Option Chain
Financials
Why DHR Down?
Discussions
Forecast
Stock Split
Dividend History
Danaher Corp stock is traded at $187.15, with a volume of 4.87M.
It is down -1.55% in the last 24 hours and down -10.68% over the past month.
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life sciences and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.
See More
Previous Close:
$190.10
Open:
$191.77
24h Volume:
4.87M
Relative Volume:
1.26
Market Cap:
$132.34B
Revenue:
$24.57B
Net Income/Loss:
$3.60B
P/E Ratio:
37.05
EPS:
5.051
Net Cash Flow:
$5.26B
1W Performance:
-2.27%
1M Performance:
-10.68%
6M Performance:
+3.14%
1Y Performance:
-11.89%
1-Day Range:
$184.99
$192.96
1-Week Range:
$184.99
$193.75
52-Week Range:
$171.00
$242.80
Danaher Corp Stock (DHR) Company Profile
Name
Danaher Corp
Sector
Industry
Phone
(202) 828-0850
Address
2200 PENNSYLVANIA AVE. N.W., WASHINGTON, DC
Compare DHR vs TMO, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DHR
Danaher Corp
|
187.15 | 134.43B | 24.57B | 3.60B | 5.26B | 5.051 |
TMO
Thermo Fisher Scientific Inc
|
490.77 | 182.14B | 44.56B | 6.72B | 6.29B | 17.74 |
IDXX
Idexx Laboratories Inc
|
575.72 | 45.40B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
112.98 | 32.27B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
302.32 | 29.62B | 3.17B | 642.63M | 516.49M | 10.77 |
Danaher Corp Stock (DHR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Goldman | Buy |
| Dec-02-25 | Initiated | Morgan Stanley | Overweight |
| Oct-08-25 | Downgrade | Rothschild & Co Redburn | Buy → Neutral |
| Jul-11-25 | Upgrade | Scotiabank | Sector Perform → Sector Outperform |
| Apr-10-25 | Upgrade | Barclays | Equal Weight → Overweight |
| Mar-21-25 | Upgrade | Goldman | Neutral → Buy |
| Mar-14-25 | Upgrade | Stifel | Hold → Buy |
| Feb-03-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Dec-23-24 | Initiated | Scotiabank | Sector Perform |
| Dec-19-24 | Initiated | Guggenheim | Buy |
| Dec-13-24 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-31-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Oct-01-24 | Initiated | Stephens | Overweight |
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Apr-17-24 | Upgrade | HSBC Securities | Hold → Buy |
| Jan-24-24 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-18-23 | Initiated | HSBC Securities | Hold |
| Dec-13-23 | Resumed | Wolfe Research | Peer Perform |
| Dec-07-23 | Downgrade | Goldman | Buy → Neutral |
| Jul-19-23 | Initiated | Raymond James | Outperform |
| May-01-23 | Initiated | SVB Securities | Outperform |
| Apr-26-23 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-18-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-05-23 | Downgrade | Credit Suisse | Outperform → Neutral |
| Dec-14-22 | Initiated | Deutsche Bank | Buy |
| Oct-24-22 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Aug-17-22 | Resumed | Bernstein | Outperform |
| Jul-20-22 | Initiated | UBS | Buy |
| Jun-01-22 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-11-22 | Initiated | Bernstein | Outperform |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Sep-10-21 | Reiterated | BofA Securities | Buy |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-23-21 | Reiterated | Goldman | Buy |
| Jul-16-21 | Initiated | The Benchmark Company | Buy |
| Apr-07-21 | Resumed | Robert W. Baird | Outperform |
| Mar-03-21 | Resumed | Barclays | Overweight |
| Dec-02-20 | Initiated | Goldman | Buy |
| Nov-25-20 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Jun-16-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Apr-02-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Mar-26-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Feb-03-20 | Reiterated | Needham | Buy |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Resumed | Stifel | Hold |
| Oct-28-19 | Reiterated | Needham | Buy |
| Oct-14-19 | Resumed | Credit Suisse | Outperform |
| Jul-19-19 | Reiterated | Needham | Buy |
| Jun-11-19 | Initiated | Piper Jaffray | Neutral |
| May-30-19 | Initiated | Wolfe Research | Outperform |
| Apr-17-19 | Reiterated | Needham | Buy |
| Feb-28-19 | Reiterated | Needham | Buy |
| Feb-25-19 | Upgrade | Janney | Neutral → Buy |
| Jan-03-19 | Initiated | Needham | Buy |
| Apr-20-18 | Reiterated | Stifel | Buy |
View All
Danaher Corp Stock (DHR) Latest News
Is It Time To Reassess Danaher (DHR) After Recent Share Price Weakness? - simplywall.st
DoorDash Inc stock faces pressure amid slowing growth and rising competition in delivery market - AD HOC NEWS
Best Biotech Stocks To Follow NowMarch 25th - MarketBeat
Danaher (NYSE: DHR) 2026 proxy outlines governance, pay and $9.9B Masimo deal - Stock Titan
Form ARS DANAHER CORP /DE/ For: Dec 31 - StreetInsider
Form DEFA14A DANAHER CORP /DE/ - StreetInsider
DAVENPORT & Co LLC Lowers Holdings in Danaher Corporation $DHR - MarketBeat
Stock Report: Can Danaher Corporation withstand a market correctionRate Hike & Capital Efficient Trading Techniques - baoquankhu1.vn
Danaher Corp. stock faces pressure amid life sciences slowdown and biotech funding crunch - AD HOC NEWS
Danaher Corp. Stock Hits Day Low Amid Price Pressure, Closing at $187.97 - Markets Mojo
Danaher (DHR) Projects 2026 Revenue Growth at TD Cowen 46th Annual Health Care Conference - Insider Monkey
Spotting Winners: Danaher (NYSE:DHR) And Research Tools & Consumables Stocks In Q4 - Yahoo! Finance Canada
Danaher Corporation (NYSE:DHR) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Leica Biosystems Solidifies Leadership in Digital Pathology with Launch of Next-Generation Aperio GT Elite Scanner and Aperio iQC Software - PR Newswire
Danaher (DHR) withdraws guarantor class for 0.200% Senior Notes due 2026 - Stock Titan
Quarterly Recap: What is the next catalyst for Danaher CorporationWeekly Market Report & Technical Confirmation Alerts - baoquankhu1.vn
Cytiva and San Raffaele Telethon Institute for Gene Therapy (SR-TIGET) launch collaboration to advance next-generation genomic medicine platforms - Ricerca Malattie Genetiche Rare
5 Best Diagnostics and Research Stocks to Buy According to Analysts - Insider Monkey
Biotech Stocks Worth WatchingMarch 22nd - MarketBeat
Danaher Corporation $DHR Shares Sold by Nordea Investment Management AB - MarketBeat
After 5 long years, is this S&P 500 stock finally ready to bounce back? - Yahoo Finance UK
Danaher Stock: EPS Is Accelerating Toward $9 and Analysts Set $265 Mean Target - TIKR.com
Covea Finance Acquires 46,700 Shares of Danaher Corporation $DHR - MarketBeat
Sandhill Capital Partners LLC's Danaher Corp(DHR) Holding History - GuruFocus
Danaher Corp (NY: DHR - The Chronicle-Journal
Danaher will post Q1 results at 6 a.m. before April 21 call - Stock Titan
Is Danaher Corporation (DHR) A Good Stock To Buy Now? - Insider Monkey
Promising Biotech Stocks To Follow TodayMarch 20th - MarketBeat
Danaher Corp. Experiences Revision in Stock Evaluation Amid Market Volatility - Markets Mojo
Union Bancaire Privee UBP SA Has $13.93 Million Stake in Danaher Corporation $DHR - MarketBeat
Swiss Life Asset Management Ltd Has $20.41 Million Stake in Danaher Corporation $DHR - MarketBeat
Danaher Corporation $DHR Shares Sold by Park National Corp OH - MarketBeat
Coastline Trust Co Acquires 5,312 Shares of Danaher Corporation $DHR - MarketBeat
CIBC Bancorp USA Inc. Makes New Investment in Danaher Corporation $DHR - MarketBeat
Argent Capital Management LLC Sells 10,889 Shares of Danaher Corporation $DHR - MarketBeat
DHR Stock Price, Quote & Chart | DANAHER CORP (NYSE:DHR) - ChartMill
Danaher (DHR) Jumps on Improved Q3 Earnings - MSN
Danaher Corporation $DHR Shares Bought by Mirova - MarketBeat
AIA Group Ltd Trims Stock Position in Danaher Corporation $DHR - MarketBeat
Danaher to buy Masimo (MASI) for $180 a share; $305M breakup fee - Stock Titan
Danaher Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
Danaher's Focus on Continuous Improvement Sets It Apart From Other Roll-Up Strategies - Morningstar
Movement Recap: Will Danaher Corporation outperform tech stocksMarket Performance Summary & Real-Time Chart Breakout Alerts - baoquankhu1.vn
Wilmington Savings Fund Society FSB Decreases Stock Holdings in Danaher Corporation $DHR - MarketBeat
Danske Bank A S Acquires Shares of 371,722 Danaher Corporation $DHR - MarketBeat
CIBC Private Wealth Group LLC Has $402.41 Million Stock Position in Danaher Corporation $DHR - MarketBeat
Danica Pension Livsforsikringsaktieselskab Takes Position in Danaher Corporation $DHR - MarketBeat
DHR Forecast, Price Target & Analyst Ratings | DANAHER CORP (NYSE:DHR) - ChartMill
Danaher Corp. stock outperforms competitors on strong trading day - MarketWatch
10 Health Care Stocks Whale Activity In Today's Session - Benzinga
Danaher said to near $10 billion deal for Masimo, FT reports - MSN
Danaher Corp Stock (DHR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.10%
1.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):